chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling of lymph nodes in armpit of arm that was vaccinated; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 07Jul2021 at 09:45 (at the age of 12-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included vitamin B12 (MANUFACTURER UNKNOWN) and ascorbic acid /pyridoxal phosphate /biotin /folic acid /colecalciferol /calcium pantothenate /ascorbyl palmitate /cocarboxylase /calcium citrate /tocopheryl acid succinate /calcium ascorbate /magnesium aspartate /betacarotene /manganese /molybdenum /chromium /copper /vanadium /iodine /selenium /mecobalamin /magnesium ascorbate /zinc gluconate /bioflavonoids nos /nicotinamide ascorbate /riboflavin phosphate /boron citrate (MULTIVITAMIN); both from unknown dates for unspecified indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 16Jun2021 (at the age of 12-year-old), as a single dose for COVID-19 immunisation. The patient previously received clotrimazole (LOTRIMIN) on an unknown date for an unspecified indication and experienced drug allergy. On 08Jul2021 at 09:00, the patient experienced swelling of lymph nodes in armpit of arm that was vaccinated. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling of lymph nodes in armpit of arm that was vaccinated was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Very strong shaking chills; lymph nodes was swollen and sore; lymph nodes was swollen and sore; Headache; arm was sore, Arm became more sore; body aches; Fatigue; Very strong shaking chills, fever of 101; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PAIN IN EXTREMITY (arm was sore, Arm became more sore), MYALGIA (body aches), FATIGUE (Fatigue) and PYREXIA (Very strong shaking chills, fever of 101) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced HEADACHE (Headache), PAIN IN EXTREMITY (arm was sore, Arm became more sore), MYALGIA (body aches), FATIGUE (Fatigue) and PYREXIA (Very strong shaking chills, fever of 101). On 08-Feb-2021, the patient experienced LYMPHADENOPATHY (lymph nodes was swollen and sore) and LYMPH NODE PAIN (lymph nodes was swollen and sore). On an unknown date, the patient experienced CHILLS (Very strong shaking chills). On 07-Feb-2021, HEADACHE (Headache), MYALGIA (body aches) and PYREXIA (Very strong shaking chills, fever of 101) had resolved. At the time of the report, PAIN IN EXTREMITY (arm was sore, Arm became more sore), FATIGUE (Fatigue), LYMPHADENOPATHY (lymph nodes was swollen and sore), LYMPH NODE PAIN (lymph nodes was swollen and sore) and CHILLS (Very strong shaking chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Ibuprofen and pain relievers
I received my Moderna vaccine Friday, Feb 26th, 2021. Initially I only had pain in the injection site, but this evening at about 6:00pm, Feb 27, I started getting a more frequent cough, runny nose, achy back, legs and neck. And at 10:00pm my temp was 101.6.
Soreness, Redness, swelling at injection site. Fever, headache, body aches.
I experienced body aches and major fatigue right after receiving the vaccine on 03-04-21.  It was worse on the second day.  On the third day my right hip area and right leg was very sore and tender to the touch and noticed a rash on my hip area.  The rash spread all over my right leg and foot and the pain got worse.  My toes and foot became numb.  I took Tylenol and Aleve to relieve the pain for a few days however I did not improve for a week.  I visited an emergency care on 03-13-21 and was diagnosed with Shingles and I was prescribed Famiclovir.  I started taking  the meds as of yesterday and I am still experiencing pain all over my leg and numb foot.
left arm rash, itch, no treatment, continuing as of 5 days after start of rash onset
Information has been received from a physician concerning a female who was vaccinated with a first dose of hep b vaccine recombinant. The physician reported that the pt's mother stated that the pt had swelling and fever of 102 deg. F. following the injection. At the time of this report, the pt had not received medical attention for her experience. Additional info has been requested.
Neck pain and headache for three weeks following vaccination. Self-treated with ibuprofen. The pain seemed to be along the trigeminal nerve on the right side of my neck, face and head. I had Shingles in this same nerve about four years ago and wonder if the vaccine could have triggered a small recurrence of the Shingles neuralgia.
Itching/pruritus; Hives on her body and face/still experiencing hives everyday,hives are not going away/Hives started along jawline; COVID arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives on her body and face/still experiencing hives everyday,hives are not going away/Hives started along jawline), VACCINATION COMPLICATION (COVID arm) and PRURITUS (Itching/pruritus) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A214) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Omnicef (cefdinir) antibiotic. The patient had hives since 2007 when she was allergic to omnicef). Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (LO LOESTRIN FE) for Birth control.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced URTICARIA (Hives on her body and face/still experiencing hives everyday,hives are not going away/Hives started along jawline) and VACCINATION COMPLICATION (COVID arm). On an unknown date, the patient experienced PRURITUS (Itching/pruritus). At the time of the report, URTICARIA (Hives on her body and face/still experiencing hives everyday,hives are not going away/Hives started along jawline) had not resolved and VACCINATION COMPLICATION (COVID arm) and PRURITUS (Itching/pruritus) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Follow-up information  received on 08-Apr-2021 contains information include reporter contact details were updated, event verbatim was updated, event outcome was updated. On 18-May-2021: Follow-up information  received on  18-May-2021 contains information include relevant medical history was updated, De and re challenge details were updated, concomitant medication was updated, treatment information was added.
Patient reported localized inflammation from arm to elbow, fever, headache, fatigue, headache.  Patient symptoms started about an hour after receiving vaccine on 9/20/23.  Patient went to MD office for visit 9/21/23 and was recommended benadryl, ibuprofen, and tylenol.  Pharmacist recommended adding ice treatment 9/21/23.
Patient was given her first Pfizer Covid shot in her LUA at 3:15. After the shot one of the school nurses notice during observation that she stood up and looked lie she wanted to pass out.  The nurse accompanied the patient to a nearby cot where she laid her down.  The patient c/o lightheadedness,  dry fuzzy throat.  Patient's extremities were cold to touch, eyes rolling back, hand posturing (stiff and cold), shaking., 62 pulse. No problems breathing or swollen throat.  Blood pressure was 119/67 at 3:25 and pulse was 80.  Nurse elevated patient legs for about 10 minutes, patient felt dizzy, shaking, apparent panicking eyes still rolling back.  She was able to respond to simple commands.  Still fuzzy throat.  Administer 50mg IM in RUE at 3:34p.m.  Blood pressure 116/71 at 3:35.  Patient's face cheeks started to look red and warm. Blood pressure 123/76 at 3:39p.m.  We called 911 at 3:46p.m.  Blood pressure 117/78 at 3:52, temperature 97.5 degrees.  Paramedics arrived 3:54p.m.  Blood pressure taken by paramedics:142/86, O2 saturation 70%, started oxygen via nasal canula at 3:56. Gave epinephrine 0.5ml IM in left upper thigh.  Started IV line at 4:00p.m.  Red tonsils, lungs diminished but clear. 4:02p.m. transported by paramedics to Hospital.
Presented in office 3/30/06 with itchy papules x 4-6 days. Scabbed over papules GU, abdomen, and neck. Dx with Varicella. Hx Varivax 5/9/00.
This case was reported by a nurse via sales rep and described the occurrence of fever in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever, fatigue, shivering and myalgia. On an unknown date, the outcome of the fever, fatigue, shivering and myalgia were unknown. It was unknown if the reporter considered the fever, fatigue, shivering and myalgia to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient was running a fever, fatigue, shivering and myalgia and missed a days work. The reporter agreed for follow up. This case has been linked with case US2018GSK153229, reported by the same reporter.
COVID-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID-like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced VACCINATION COMPLICATION (COVID-like symptoms). At the time of the report, VACCINATION COMPLICATION (COVID-like symptoms) outcome was unknown.            No concomitant and treatment information were reported by the reporter.  Caller mentioned she received 2nd dose of the Moderna COVID-19 vaccine on the 17th Nov 2021 and was experiencing COVID-like symptoms on the 18thNov 2021.  Company comment- This case concerns a female patient, unknown age, with no relevant medical history, who experienced the non-serious, unexpected event of vaccination complication. The event occurred  one day after second dose of mRNA 1273 vaccine. The patient felt COVID-like symptoms after her vaccine. The rechallenge is not applicable as there is no information regarding a third dose. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 18-Nov-2021: Follow-up received on 18-NOV-2021 and contains NNI.; Sender's Comments: This case concerns a female patient, unknown age, with no relevant medical history, who experienced the non-serious, unexpected event of vaccination complication. The event occurred  one day after second dose of mRNA 1273 vaccine. The patient felt Covid-like symptoms after her vaccine. The rechallenge is not applicable as there is no information regarding a third dose.The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.
Fatigue and weakness, lack of appetite, body aches, chills, extreme diaphoresis. Worsened over 72 hours and peaked. No fever or GI distress during event.
A dose of Moderna Covid-19 vaccine was given after the 30-day beyond use by date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A dose of Moderna Covid-19 vaccine was given after the 30-day beyond use by date.) in an 83-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (A dose of Moderna Covid-19 vaccine was given after the 30-day beyond use by date.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A dose of Moderna Covid-19 vaccine was given after the 30-day beyond use by date.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The patient was administered first dose, second dose and first booster dose of unknown manufacturer on an unknown date. On 09-Jun-2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. Treatment information was unknown.
She started having severe headaches the day following the injection. She continues to have these headaches, dizziness and nausea on and off since receiving the vaccine
Severe arm/shouler pain.  Started one day after vaccine.  Severe enough that it is not dulled by 600 mg of ibuprofen.  4 weeks after vaccine(before second dose) range of mption of arm is still limited.
Swelling at site of injection, soreness and stiffness of left arm Narrative:  Other Relevant History:
Migraine, nausea, muscle soreness from left arm to shoulder to neck, restlessness
Cold chills, blue fingers both hands, with dark blue dots under skin, nausea. Did not seek medical opinion.  Symptoms subsided within  an hour.  No fever.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported.  No treatment medications were not provided.  It was reported that there have been no power outages that would have impacted the Moderna vaccine. However, reporter reiterated that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger that caller was unable to download for the months of DEC2021, JAN2022, and FEB2022. Reporter said that they are filling out a temperature excursion assessment at this time and she was calling in to report the same to Moderna.  Reporter confirmed that patients have been administered doses while the temperature excursion assessment has been ongoing. It was reported that no adverse reactions were reported by any patients.
Student became diaphoretic, his eyes rolled back and fell to the floor while sitting on the chair and sustained laceration wound to his (R) lower lip and abrasion to (R) shoulder. Student also stiffened up for < 5 sec while on the floor and quickly tried to get up. Breathing remained even and nonlabored.
The night before I thought I was coming down with something, but I woke up with a headache, a sore throat and some achiness. I took over the counter medication since it was the weekend, and it was too late to get the prescribed medication. I was out of work for 10 days.
Initially fever light headed week shortness of breath. By Sunday March 21, 2021 sob, cough,  blood pressure shot up to 200/100. Throat makes this involuntary clearing sound and hot sweats.  Still have everything but fever and high blood pressure.
30 hours after receiving my second  Moderna vaccine I developed a 3" pink reddish spot about 1" below the injection site. Slightly raised and slightly itchy.   Of note, I had had the same reaction in the other arm following the first Moderna  shot..but that reaction occured 7 days following the shot...and was much worse..erupting as a hive..., warm, hard, itchy, red.  (previously reported to VAERS)  This reaction does not appear as severe as the first one.
swelling in both legs; pain; venous insufficiency; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SWELLING (disability), outcome "unknown", described as "swelling in both legs"; PAIN (disability), outcome "unknown", described as "pain"; PERIPHERAL VENOUS DISEASE (disability), outcome "unknown", described as "venous insufficiency". Clinical course: I want you to know that I had two vaccine shots plus a booster. All Pfizer. As a result I wound up with venous insufficiency, pain and swelling in both legs with permanent disability.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient?s parent called reporting that on 07/25/2023, the client received an expired vaccine. Parent states the client received four shots, and while checking out, the staff realized one vaccine expired on 07/08/2023. Patient was told that the clinic would be contacting the health department on what to do and if the vaccine was still viable after it expired. The Health Department did not receive a call. Parent was concerned for their child because this is not the first time something like this has happened, and so contacted the Health Department themselves. Patient?s record has the patient receiving MMR, Varicella, Hib, and Dtap-IPV on 07/25/2023. All vaccine information reported in this form is from system. The MMR, Varicella, and Hib are entered under the clinic, but the Dtap-IPV is entered as Historical without lot# and Expiration.
11/17/22 I was doing volunteer work. The pharmacy on the base was closed for training, and everyone was upset. It was very stressful dealing with some rude people. I had been in pain for over an hour. I took deep breaths hoping it would go away. It was sharp pain going from the back of my shoulder through my left breast. I had it when I was pregnant and was told it was heartburn. This did not go away until I got home, over an hour from onset. I have an ECG app on my watch and it showed I was in Sinus rhythm the whole time. I was on my way to the emergency room and by that time, I was calm, and it was over, so I did not go. I was concerned, even though I did not have other symptoms of a heart attack. I saw my Neurologist with an already scheduled appointment I had and he referred me to my PCP. My appointment with my PCP is in a week.
welt is larger and around the skin is pink; Underneath it feels like a lump; rash next to the injection site, it was swollen, itchy and hot to the touch.; rash next to the injection site, it was swollen, itchy and hot to the touch; a rash next to the injection site, it was swollen, itchy and hot to the touch.; rash next to the injection site, it was swollen, itchy and hot to the touch.; A spontaneous report was received from a consumer concerning a 55-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash next to the injection site, it was swollen, itchy and hot to the touch and welt is larger and around the skin is pink, and underneath it feels like a lump.  The patient's medical history was not provided. Concomitant medications reported were vitaminas for drug use for unknown indication.  On 2 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: not provided) via unknown route for prophylaxis of COVID-19 infection.  On 10 Feb 2021, the patient experienced the event(s) rash next to the injection site, it was swollen, itchy and hot to the touch. a. On 11 Feb 2021, the patient experienced the event(s) welt is larger and around the skin is pink, and underneath it feels like a lump.  Treatment details were not provided. Patient gives consent for Safety to follow case.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), rash next to the injection site, it was swollen, itchy and hot to the touch and welt is larger and around the skin is pink, and underneath it feels like a lump was unknown.
Extreme pain at site of injection. Patient said she could not sleep. Better on 10/13; completely fine 10/17. No residual effects.
The pt experienced redness, swelling and increased warmth at the site. The pt was seen by her MD and prescribed an antibiotic. The pt used warm alternated with cool intermittent compresses to the site.
Pain at the vaccination site on day of vaccination, followed by lower back and knee pain when trying to move over the two weeks preceding second shot.
Chill and high fever up to 103F, generalized muscle ache and enable to stand on feet for several hours, generalized joint pain, diarrhea and nasal congestion. Symptom started 18 hours after the injection, lasted for 18 hours, improved for a few hours, and recurrent on day 3 of vaccination. Lethargy and dehydration. Symptoms  do not alleviate much by constant use of Motrin.